Skip to content

A study on course, pathology and outcomes of the upcoming rare cancers in children

Clinical Course, Pathological Spectrum and Outcomes in Paediatric Rare Tumours in India: A Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/02/017851
Enrollment
250
Registered
2019-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D498- Neoplasm of unspecified behavior of other specified sites

Interventions

Intervention1: NA: NA Control Intervention1: NA: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All children less than 18 years of age newly diagnosed with a diagnosis of a Paediatric Rare Tumour ( as defined in Annexure 1 ) 2. Informed Consent to participate in the study 3. Children diagnosed/started on treatment elsewhere during the study period and referred for the continuation of therapy to the participating centre can be included 4. Cases who have been diagnosed within the study period but are deceased will be eligible.

Exclusion criteria

Exclusion criteria: Absence of conclusive diagnosis, either by histology or molecular diagnostics

Design outcomes

Primary

MeasureTime frame
To study the incidence and epidemiology of specific paediatric Rare Tumours being diagnosed at multiple centres across the countryTimepoint: After diagnosis, Before Treatment,During treatment, After treatment.

Secondary

MeasureTime frame
1.To record the management offered to these patients 2.To analyse outcome of these patients 3.To estimate the incidence and causes of Treatment Refusal and Abandonment (TR&A) in these patients Timepoint: After diagnosis, Before Treatment,During treatment, After treatment.

Countries

India

Contacts

Public ContactDr Hemanth Kumar

Tata Memorial Hospital

maya.prasad@gmail.com9819379113

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026